Exploring In Vitro & In Vivo Models to Better Understand AAV Vector Specificity
Time: 8:30 am
day: Conference Day Two
Details:
- Appreciating the advancements made to getting to CNS tissue but realizing the opportunity to use effective gene editing techniques to enhance tissue targeting
- Utilizing in vitro and in vivo models to test AAV vectors specificity for CNS delivery
- Discussing future thoughts: how can more human-based in vitro models improve testing in specific indications and thus enhance translatability?
